Oppenheimer Remains Sidelined on Ambarella (AMBA) Following 3Q
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Pre-Open Stock Movers 12/02: (NVCN) (FIVE) (ULTA) Higher; (CVM) (WDAY) (AMBA) Lower (more...)
December 2, 2016 9:28 AM ESTToday's Pre-Open Stock Movers
Neovasc, Inc., (NASDAQ: NVCN) 87.8% HIGHER; Boston Scientific Corporation (NYSE: BSX) today announced a definitive agreement to acquire certain manufacturing assets and capabilities of the Neovasc, Inc., (NASDAQ: NVCN) (TSX: NVC) advanced biological tissue business, as well as a 15% equity stake in Neovasc, for a total of $75 million in cash. The Neovasc advanced biological tissue business makes elements used in transcatheter heart valves, including the Boston Scientific Lotus Valve System.* Upon completion of the transaction, the... More
After-Hours Stock Movers 12/01: (FIVE) (ULTA) (ASNA) Higher; (WDAY) (AMBA) (GIII) Lower (more...)
December 1, 2016 6:02 PM ESTToday's After-Hours Movers
CEL-SCI Corporation (NYSE: CVM) 28% LOWER; announced that it intends to offer and sell, subject to market and other conditions shares of its common stock and warrants to purchase common stock. The securities are to be sold by CEL-SCI subject to market and other conditions in a public offering.
Five Below (NASDAQ: FIVE) 13.1% HIGHER; reported Q3 EPS of $0.10, in-line with the analyst estimate of $0.10. Revenue for the quarter came in at $199.5 million versus the consensus estimate... More
Ambarella (AMBA) Tops Q3 EPS by 17c
December 1, 2016 4:06 PM ESTAmbarella (NASDAQ: AMBA) reported Q3 EPS of $1.11, $0.17 better than the analyst estimate of $0.94. Revenue for the quarter came in at $100.5 million versus the consensus estimate of $97.3 million.
GUIDANCE:
Ambarella sees Q4 2017 revenue of $84-87 million, versus the consensus of $90.3... More
Trading Radar for 12/1: Kroger (KR), Express (EXPR), Ambarella (AMBA), Smith & Wesson (SWHC) Report
November 30, 2016 3:46 PM ESTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
8:30am EST
Earnings:
Christopher & Banks (NYSE:... More
Ambarella (AMBA) volatility elevated into Q3 and outlook
November 30, 2016 12:41 PM ESTAmbarella (NASDAQ: AMBA) December weekly call option implied volatility is at 108, December is at 67; compared to its 52-week range of 41 to 91 into the expected release of Q3 results on December 1.
... More
Ambarella (AMBA) on Watch Amid GoPro (GPRO) Restructuring, HERO5 Sales
November 30, 2016 7:24 AM ESTAmbarella (Nasdaq: AMBA) shares are on watch this morning after GoPro Inc. (Nasdaq: GPRO)... More

